Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT04784351
Other study ID # 2017P002583b
Secondary ID
Status Active, not recruiting
Phase
First received
Last updated
Start date March 20, 2021
Est. completion date December 1, 2021

Study information

Verified date April 2021
Source Brigham and Women's Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This is a retrospective observational study drawing on data from the Brigham and Women's Home Hospital database. Sociodemographic and clinic data from a training cohort were used to train a machine learning algorithm to predict length of stay throughout a patient's admission. This algorithm was then validated in a validation cohort.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 500
Est. completion date December 1, 2021
Est. primary completion date August 1, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Was a subject in the Brigham and Women's Home Hospital study and has a completed record in the study's database.

Study Design


Locations

Country Name City State
United States Brigham and Women's Faulkner Hospital Boston Massachusetts
United States Brigham and Women's Hospital Boston Massachusetts

Sponsors (2)

Lead Sponsor Collaborator
Brigham and Women's Hospital Biofourmis Inc.

Country where clinical trial is conducted

United States, 

References & Publications (11)

Bacchi S, Oakden-Rayner L, Menon DK, Jannes J, Kleinig T, Koblar S. Stroke prognostication for discharge planning with machine learning: A derivation study. J Clin Neurosci. 2020 Sep;79:100-103. doi: 10.1016/j.jocn.2020.07.046. Epub 2020 Aug 5. — View Citation

Daghistani TA, Elshawi R, Sakr S, Ahmed AM, Al-Thwayee A, Al-Mallah MH. Predictors of in-hospital length of stay among cardiac patients: A machine learning approach. Int J Cardiol. 2019 Aug 1;288:140-147. doi: 10.1016/j.ijcard.2019.01.046. Epub 2019 Jan 19. — View Citation

Karnuta JM, Churchill JL, Haeberle HS, Nwachukwu BU, Taylor SA, Ricchetti ET, Ramkumar PN. The value of artificial neural networks for predicting length of stay, discharge disposition, and inpatient costs after anatomic and reverse shoulder arthroplasty. J Shoulder Elbow Surg. 2020 Nov;29(11):2385-2394. doi: 10.1016/j.jse.2020.04.009. Epub 2020 Jun 9. — View Citation

Lubelski D, Ehresman J, Feghali J, Tanenbaum J, Bydon A, Theodore N, Witham T, Sciubba DM. Prediction calculator for nonroutine discharge and length of stay after spine surgery. Spine J. 2020 Jul;20(7):1154-1158. doi: 10.1016/j.spinee.2020.02.022. Epub 2020 Mar 13. — View Citation

Ma X, Si Y, Wang Z, Wang Y. Length of stay prediction for ICU patients using individualized single classification algorithm. Comput Methods Programs Biomed. 2020 Apr;186:105224. doi: 10.1016/j.cmpb.2019.105224. Epub 2019 Nov 20. — View Citation

Merrill RK, Ferrandino RM, Hoffman R, Shaffer GW, Ndu A. Machine Learning Accurately Predicts Short-Term Outcomes Following Open Reduction and Internal Fixation of Ankle Fractures. J Foot Ankle Surg. 2019 May;58(3):410-416. doi: 10.1053/j.jfas.2018.09.004. Epub 2019 Feb 23. — View Citation

Navarro SM, Wang EY, Haeberle HS, Mont MA, Krebs VE, Patterson BM, Ramkumar PN. Machine Learning and Primary Total Knee Arthroplasty: Patient Forecasting for a Patient-Specific Payment Model. J Arthroplasty. 2018 Dec;33(12):3617-3623. doi: 10.1016/j.arth.2018.08.028. Epub 2018 Sep 5. — View Citation

Nemati M, Ansary J, Nemati N. Machine-Learning Approaches in COVID-19 Survival Analysis and Discharge-Time Likelihood Prediction Using Clinical Data. Patterns (N Y). 2020 Aug 14;1(5):100074. doi: 10.1016/j.patter.2020.100074. Epub 2020 Jul 4. — View Citation

Ramkumar PN, Navarro SM, Haeberle HS, Karnuta JM, Mont MA, Iannotti JP, Patterson BM, Krebs VE. Development and Validation of a Machine Learning Algorithm After Primary Total Hip Arthroplasty: Applications to Length of Stay and Payment Models. J Arthroplasty. 2019 Apr;34(4):632-637. doi: 10.1016/j.arth.2018.12.030. Epub 2018 Dec 27. — View Citation

Sinha I, Aluthge DP, Chen ES, Sarkar IN, Ahn SH. Machine Learning Offers Exciting Potential for Predicting Postprocedural Outcomes: A Framework for Developing Random Forest Models in IR. J Vasc Interv Radiol. 2020 Jun;31(6):1018-1024.e4. doi: 10.1016/j.jvir.2019.11.030. Epub 2020 May 4. — View Citation

Young AJ, Hare A, Subramanian M, Weaver JL, Kaufman E, Sims C. Using Machine Learning to Make Predictions in Patients Who Fall. J Surg Res. 2021 Jan;257:118-127. doi: 10.1016/j.jss.2020.07.047. Epub 2020 Aug 18. — View Citation

* Note: There are 11 references in allClick here to view all references

Outcome

Type Measure Description Time frame Safety issue
Primary Length of Stay The time spent by each patient in Home Hospital from time of admission to time of discharge, measured in hours From date of admission to date of discharge (1 to 24 days)
See also
  Status Clinical Trial Phase
Terminated NCT04410523 - Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma Phase 2
Completed NCT04624425 - Additional Effects of Segmental Breathing In Asthma N/A
Active, not recruiting NCT03927820 - A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR) N/A
Completed NCT04617015 - Defining and Treating Depression-related Asthma Early Phase 1
Recruiting NCT03694158 - Investigating Dupilumab's Effect in Asthma by Genotype Phase 4
Terminated NCT04946318 - Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma Phase 2
Completed NCT04450108 - Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients N/A
Completed NCT03086460 - A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH) Phase 2
Completed NCT01160224 - Oral GW766944 (Oral CCR3 Antagonist) Phase 2
Completed NCT03186209 - Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE) Phase 3
Completed NCT02502734 - Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma Phase 3
Completed NCT01715844 - L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics Phase 1
Terminated NCT04993443 - First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036 Phase 1
Completed NCT02787863 - Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology Phase 4
Recruiting NCT06033833 - Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study Phase 2
Completed NCT03257995 - Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma. Phase 2
Completed NCT02212483 - Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients N/A
Recruiting NCT04872309 - MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
Withdrawn NCT01468805 - Childhood Asthma Reduction Study N/A
Recruiting NCT05145894 - Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device